Cannabinoids and immunity to viruses

Advances in Experimental Medicine and Biology

Volumn 402, Issue , 1996, Pages 131-134

  Specter, Steven ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID DERIVATIVE; TETRAHYDROCANNABINOL;

CANNABIS ADDICTION; CONFERENCE PAPER; DISEASE ASSOCIATION; FRIEND LEUKEMIA VIRUS; HERPES SIMPLEX VIRUS; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS INFECTION; SUPERINFECTION; VIRUS IMMUNITY; VIRUS INFECTION;

CANNABIS; FRIEND MURINE LEUKEMIA VIRUS; HERPES; SIMPLEXVIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0029797227     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4613-0407-4_18     Document Type: Conference Paper

References (11)

1. Juel-Jensen, B.E. Cannabis and recurrent herpes simplex. Brit. Med. J. 4: 296, 1972.
2. Friedman, H., Klein, T. and Specter, S. Immunosuppression by marijuana and components. In: Psychoneuroimmunology, 2nd Edition, Ader, R., Cohen, N. and Felten, D. (Eds), Academic Press, Orlando, 1991 pp. 931-953.
3. Morahan, P.S., Klykken, P.C., Smith, S.H., Harris, L.S. and Munson, A.E. Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus. Infect. Immun. 23: 670-674, 1979.
4. Cabral, G.A., Mishkin, E.M. and Holsapple, M.P. Delta-9-tetrahydrocannabinol decreases host resistance to herpes simplex virus type 2 vaginal infection in the guinea pig. In: Marijuana 84. Proc. Oxford Symp. on Cannabis, IRL Press, 1985, pp. 431-438.
5. Cabral, G.A., Lockmuller, J.C. and Mishkin, E.M. Delta-9-tetrahydrocannabinol decreases alpha/beta Interferon response to herpes simplex virus type 2 in the B6C3F1 mouse. Proc. Soc. Exp. Biol. Med. 181: 305-311, 1986.
6. Cabral, G.A., and Vasquez, R. Delta-9-tetrahydrocannabinol suppresses macrophage extrinsic antiherpesvirus activity. Proc. Soc. Exp. Biol. Med. 199: 255-263, 1992.
7. Cabral, G.A., Dove-Pettit, D.A. and Fischer-Stenger, K. Marijuana and host resistance to herpesvirus infection. In: Drugs of Abuse, Immunity and AIDS Friedman, H., Klein, T.W. and Specter, S. (Eds.) Adv. Exp. Med. Biol. 335: 95-106, 1993.
8. Lancz, G., Specter, S. and Brown, H.K. Suppressive effects of delta-9-tetrahydrocannabinol on herpes simplex virus infectivity in vitro. Proc. Soc. Exp. Biol. Med. 196: 401-404, 1991.
9. Lancz, G., Specter, S., Brown, H.K., Hackney, J.F. and Friedman, H. Interaction of delta-9-tetrahydrocannabinol with herpes simplex virus and cultural conditions associated with drug-induced anti-cellular effects. In: Drugs of Abuse, Immunity and Immunodeficiency, Friedman, H., Specter, S. and Klein, T (Eds.), Adv. Exp. Med. Biol. 288: 287-304, 1991.
10. Specter, S., Lancz, G., Westrich, G. and Friedman, H. Combined immunosuppressive activities of delta-9-tetrahydrocannabinol and murine retrovirus. In: Drugs of Abuse, Immunity and Immunodeficiency, Friedman, H., Specter, S. and Klein, T (Eds.). Adv. Exp. Med. Biol. 288: 135-142, 1991.
11. Specter, S., Lancz, G., Westrich, G. and Friedman, H. Delta-9-tetrahydrocannabinol augments murine retroviral induced iminunosuppression and opportunistic infection. Int. J. Immunopharmac. 13: 411-417, 1991.